Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Oncology Nursing|August 3, 2021
Tisagenlecleucel Therapy: Nursing Considerations for the Outpatient SettingKathleen Cunningham, Heather DiFilippo, Kelli Henes, et al.
Seminars in Oncology Nursing|March 5, 2024
The Patient Symptom Experience After Tisagenlecleucel and Lisocabtagene Maraleucel CAR T-Cell Therapy for LymphomaLucy Andersen, Kayla M Baker, Heather Difilippo, et al.
Seminars in Oncology Nursing|September 26, 2023
Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple MyelomaMary Steinbach, Laura J Zitella, Erika Florendo, et al.
JCO Oncology Practice|May 13, 2025
Long-Term Quality of Life, Cognitive Function, and Symptom Burden Among Chimeric Antigen Receptor T-Cell Recipients and Associated Cytokine Release Syndrome and NeurotoxicityLucy Andersen, Ryan J Quinn, Heather Difilippo, et al.
Transplantation and Cellular Therapy|May 23, 2025
Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their CaregiversLucy P Andersen, Ryan J Quinn, Heather Difilippo, et al.
Seminars in Oncology Nursing|August 30, 2025
Factors Related to Long-Term Caregiving Burden Among Chimeric Antigen Receptor (CAR) T-Cell Recipients and Their Informal CaregiversLucy P Andersen, Ryan J Quinn, Heather Difilippo, et al.
Transplantation and Cellular Therapy|May 21, 2023
Survival Outcomes for Patients with Relapsed/ Refractory Aggressive B Cell Lymphomas Following Receipt of High-Dose Chemotherapy/Autologous Stem Transplantation and/or Chimeric Antigen Receptor-Modified T CellsDaniel J Landsburg, Sunita D Nasta, Jakub Svoboda, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2022
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory SettingSunita D Nasta, Mitchell E Hughes, Esin C Namoglu, et al.
Future Oncology (London, England)|May 18, 2022
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myelomaDaanish Hoda, Robert Richards, Edward A Faber, et al.
Pageof 1